Trademark Overview
On Friday, September 19, 2025, a trademark application was filed for SEGO with the United States Patent and Trademark Office. The USPTO has given the SEGO trademark a serial number of 99402429. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, September 19, 2025. This trademark is owned by SEGO THERAPEUTICS INC. The SEGO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Medical diagnostic services; providing medical information in the field of pharmaceutical research and clinical trials; consulting services in the field of medical testing, diagnostics, and patient-specific therapies; providing medical information in the field of oncology, namely on radiolabeled small molecule diagnostics; consulting services in the field of medical testing and diagnostic screening for cancer.
Pharmaceutical research and development; pharmaceutical research and development services in the field of small molecule cancer therapeutics; scientific and technological services, namely, research and development in the field of cancer-related pharmaceuticals and cancer-related drug discovery; research and development of pharmaceutical preparations for treating cancer; providing online non-downloadable software platforms for screening, analyzing, and identifying potential drug candidates; providing online non-downloadable software platforms for screening, analyzing, and identifying potential drug candidates for treating cancer; pharmaceutical research services; testing, inspection, research, or development of pharmaceutical preparations for cancer; providing medical and scientific research information in the field of pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; laboratory research se...
Licensing of intellectual property
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in suppressing tumours; pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely for treating cancer; biological preparations for the treatment of cancer; small molecule pharmaceutical preparations for the treatment of cancer; small molecule pharmaceutical preparations for use in suppressing tumours; radiolabeled pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in suppressing tumours.
